
Ludiomil25 mg
SANDOZ (A Novartis Division)
Maprotiline Hydrochloride is a tetracyclic antidepressant indicated for the treatment of: Major depressive disorder (established use): including depression associated with anxiety and more.
Maprotiline Hydrochloride is a tetracyclic antidepressant indicated for the treatment of:
Maprotiline Hydrochloride is generally reserved for patients who have not responded adequately to, or cannot tolerate, first-line antidepressants such as SSRIs, given its side-effect profile. It is not indicated for bipolar mania, and use in other psychiatric conditions is not established.
Dosage of Maprotiline Hydrochloride must be individualized according to the severity of illness, patient response, and tolerability. Treatment is usually started at a lower dose and increased gradually.
| Indication/Population | Recommended Dosage |
|---|---|
| Mild to moderate depression, outpatient adults | Initial 25 mg to 75 mg per day (single or divided doses); may increase gradually as needed and tolerated, usually to a maintenance range of 75-150 mg/day |
| Severe/hospitalized depression, adults | Initial dose similar to above; may be titrated upward more cautiously under close medical supervision, not usually exceeding 225 mg/day |
| Elderly patients | Lower initial doses (e.g. 25 mg/day) are recommended due to increased sensitivity to anticholinergic and cardiovascular effects; increase more slowly |
| Maintenance therapy | Lowest effective dose, generally continued for several months after response, then tapered gradually |
Maprotiline Hydrochloride should be taken exactly as prescribed by a physician. Do not increase, decrease, stop, or share this medicine with others without medical advice. Full antidepressant effect may take 2 to 3 weeks to become apparent, and treatment should not be discontinued abruptly (see Duration of Treatment).
Side effects of Maprotiline Hydrochloride are generally dose-related and most pronounced early in treatment or with dose increases.
Patients should report any unusual or severe symptoms to their physician promptly.
Maprotiline Hydrochloride is contraindicated in the following situations:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.